HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lilia Taningco Selected Research

Lymphoma (Lymphomas)

1/2023Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lilia Taningco Research Topics

Disease

1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1Lymphoma (Lymphomas)
01/2023
1Abdominal Pain (Pain, Abdominal)
05/2015

Drug/Important Bio-Agent (IBA)

1B7-H1 AntigenIBA
01/2023
1durvalumabIBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1nilotinibFDA Link
05/2015
1Imatinib Mesylate (Gleevec)FDA Link
05/2015
1Alanine Transaminase (SGPT)IBA
05/2015
1Lipase (Acid Lipase)FDA Link
05/2015

Therapy/Procedure

1Therapeutics
01/2023